Chicago Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Chicago Trust's BIIB Position: Q3 2022 in Review
Chicago Trust sold out of Biogen (BIIB) in Q3 2022, closing a stake of 2,740 shares — an estimated $559K sold.
Chicago Trust first reported a position in BIIB in Q4 2017 and held it in 19 quarters. The position peaked at $2.6M in Q2 2021. 986 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.
- Chicago Trust reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
- Chicago Trust sold 2,740 Biogen shares in Q3 2022, an estimated $559K.
- Chicago Trust first reported a position in Biogen in Q4 2017 and held it in 19 quarters.
- Chicago Trust's Biogen position peaked at $2.6M in Q2 2021.
- 986 funds tracked by Wall St. Rank held Biogen as of Q3 2022.
Based on Chicago Trust's 13F filing for Q3 2022, filed 13 Oct 2022.